Medico Remedies Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Medico Remedies Limited cash flow conversion efficiency. Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Medico Remedies Limited (2013–2026)

Cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medico Remedies Limited share price for real-time trading data and today's change.

Medico Remedies Limited Cash Flow Conversion Ratio Explained

Medico Remedies Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency. Also see MEDICO market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
New York City REIT Inc NYSE:NYC	-0.046x
Tower Resources Ltd V:TWR	-0.017x
Procorp S.A.B. de C.V MX:PROCORPB	0.018x
United Maritime Corporation NASDAQ:USEA	-0.012x
Indara Insurance Public Company Limited BK:INSURE	0.071x
YBS International Bhd KLSE:0025	0.020x
Equity Metals Corp V:EQTY	-0.520x
Lodzia TA:LODZ	0.018x

Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. Review Medico Remedies Limited free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs754.74 Million ≈ $8.16 Million	Rs10.06 Million ≈ $108.82K	0.013x	-82.98%
2025-03-31	Rs624.69 Million ≈ $6.76 Million	Rs48.92 Million ≈ $529.06K	0.078x	+68.23%
2024-03-31	Rs523.71 Million ≈ $5.66 Million	Rs24.38 Million ≈ $263.65K	0.047x	-75.01%
2023-03-31	Rs438.43 Million ≈ $4.74 Million	Rs81.67 Million ≈ $883.25K	0.186x	+18.60%
2022-03-31	Rs373.20 Million ≈ $4.04 Million	Rs58.62 Million ≈ $633.95K	0.157x	+145.08%
2021-03-31	Rs324.58 Million ≈ $3.51 Million	Rs-113.10 Million ≈ $-1.22 Million	-0.348x	-1175.78%
2020-03-31	Rs298.66 Million ≈ $3.23 Million	Rs9.67 Million ≈ $104.62K	0.032x	-81.43%
2019-03-31	Rs282.36 Million ≈ $3.05 Million	Rs49.24 Million ≈ $532.54K	0.174x	-8.75%
2018-03-31	Rs266.66 Million ≈ $2.88 Million	Rs50.97 Million ≈ $551.17K	0.191x	+202.51%
2017-03-31	Rs163.72 Million ≈ $1.77 Million	Rs-30.52 Million ≈ $-330.12K	-0.186x	+26.28%
2016-03-31	Rs147.44 Million ≈ $1.59 Million	Rs-37.29 Million ≈ $-403.27K	-0.253x	-980.71%
2015-03-31	Rs136.14 Million ≈ $1.47 Million	Rs-3.19 Million ≈ $-34.46K	-0.023x	-107.36%
2014-03-31	Rs85.72 Million ≈ $927.00K	Rs27.27 Million ≈ $294.96K	0.318x	-21.78%
2013-03-31	Rs50.55 Million ≈ $546.71K	Rs20.57 Million ≈ $222.40K	0.407x	--

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic

Market Cap

$16.66 Million

Rs1.54 Billion INR

Market Cap Rank

#25530 Global

#1412 in India

Share Price

Rs18.56

Change (1 day)

-1.22%

52-Week Range

Rs18.56 - Rs54.24

All Time High

Rs96.70